GO:0035544 negative regulation of SNARE complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035544 describes any process that decreases the frequency, rate or extent of assembly of the SNARE complex, a four-helix bundle that drives membrane fusion.
• Negative regulators of SNARE complex assembly include RUNDC1, which restrains autophagosome-lysosome fusion by limiting STX17-SNAP29-VAMP8 assembly.
• PRRT2 acts as a direct modulator that can inhibit SNARE complex assembly, and its dysfunction is linked to synaptic fusion defects.
• Disease-associated proteins such as APOE4 and NDRG3 can dysregulate SNARE assembly, contributing to synaptic vesicle release defects and ER-to-Golgi transport changes.
• Key experimental approaches include knockout and point-mutation cell models, co-immunoprecipitation, FRET, and CRISPR library screening to identify negative regulators.
• Understanding negative regulation of SNARE complex assembly is critical for autophagy, neurotransmission, and neurodegeneration research.
Description
Membrane fusion is a fundamental cellular process that requires the assembly of SNARE complexes, which are stable ternary complexes consisting of a four-helix bundle typically formed from one R-SNARE and three Q-SNAREs. The Gene Ontology term GO:0035544, negative regulation of SNARE complex assembly, refers to any process that decreases the frequency, rate or extent of this assembly. This regulatory mechanism is essential for controlling the timing and location of membrane fusion events, preventing premature or excessive fusion that could disrupt cellular homeostasis. Researchers study this term because dysregulated SNARE complex assembly is implicated in a wide range of pathologies, including neurodegenerative diseases, autophagy-related disorders, and synaptic dysfunction. For example, the APOE4 variant, a major genetic risk factor for Alzheimer's disease, triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly. Similarly, RUNDC1 negatively mediates the fusion of autophagosomes with lysosomes by regulating SNARE complex assembly, highlighting the importance of negative regulation in autophagy. Understanding the molecular players and mechanisms that inhibit SNARE complex assembly provides insights into fundamental cell biology and offers potential therapeutic targets for related diseases.
negative regulation of SNARE complex assembly At A Glance
| GO ID | GO:0035544 |
|---|---|
| GO term | negative regulation of SNARE complex assembly |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the frequency, rate or extent of SNARE complex assembly, thereby modulating membrane fusion events. |
| Related cellular process | Autophagosome-lysosome fusion, synaptic vesicle exocytosis, ER-to-Golgi transport. |
| Key negative regulators | RUNDC1, PRRT2, and other proteins that directly or indirectly inhibit SNARE assembly. |
| Disease relevance | Neurodegeneration, synaptic disorders, autophagy-related pathologies. |
| Research methods | Knockout/knock-in cell models, co-immunoprecipitation, FRET, CRISPR screening. |
What Is GO:0035544?
GO:0035544, negative regulation of SNARE complex assembly, is a biological process defined as any process that decreases the frequency, rate or extent of assembly of the SNARE complex. The SNARE complex is a protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. This term encompasses molecular mechanisms that inhibit or restrain the formation of this complex, thereby modulating membrane fusion events such as synaptic vesicle exocytosis and autophagosome-lysosome fusion.
Why Is negative regulation of SNARE complex assembly Important in Cell Biology?
Negative regulation of SNARE complex assembly is crucial for maintaining cellular homeostasis by preventing inappropriate membrane fusion events. SNARE-mediated fusion is essential for neurotransmitter release, autophagy, and intracellular trafficking, and its dysregulation is linked to severe human diseases, including Alzheimer's disease and other neurodegenerative conditions. Understanding how proteins such as RUNDC1 and PRRT2 negatively regulate SNARE assembly provides mechanistic insights into disease pathogenesis and identifies potential therapeutic targets. Moreover, this regulatory process is conserved across evolution, as evidenced by the role of STX17-containing SNARE complexes in autophagosome fusion.
• Controls the timing and location of membrane fusion, preventing premature or excessive fusion.
• Dysregulation is implicated in Alzheimer's disease via APOE4-mediated disruption of SNARE assembly.
• RUNDC1 negatively regulates autophagosome-lysosome fusion, affecting autophagy flux.
• PRRT2 mutations are associated with neurological disorders such as paroxysmal kinesigenic dyskinesia, linked to SNARE assembly modulation.
• NDRG3, a lactate sensor, decelerates ER-to-Golgi transport by interacting with syntaxin-5, highlighting metabolic regulation of SNARE assembly.
• The DID of CAPS-1 anchors the plasma membrane to promote vesicle exocytosis, indirectly influencing SNARE complex assembly.
• Munc13-1 intramolecular regulation via a negatively charged sequence modulates synaptic exocytosis.
• ATG2A acts as a tether to regulate autophagosome-lysosome fusion, a process dependent on SNARE complex assembly.
• STX17-containing SNARE complexes are evolutionarily conserved in autophagosome fusion with endosomes and lysosomes.
• Targeting negative regulators of SNARE assembly offers potential therapeutic strategies for neurodegenerative and autophagy-related diseases.
What Happens During negative regulation of SNARE complex assembly?
Inhibition of SNARE Complex Formation
In simple terms: Certain proteins act like brakes that stop SNARE proteins from coming together to fuse membranes.
Negative regulation of SNARE complex assembly involves processes that decrease the formation of the four-helix bundle. For instance, RUNDC1 negatively mediates the fusion of autophagosomes with lysosomes by regulating SNARE complex assembly, likely by preventing the assembly of STX17-SNAP29-VAMP8 complexes. Similarly, PRRT2 directly modulates SNARE complex assembly, and its presence can inhibit assembly, thereby controlling synaptic fusion. These regulatory proteins may bind to SNARE components or interfere with their interactions, reducing the frequency or extent of assembly.
Molecular Players and Their Interactions
In simple terms: Specific proteins like RUNDC1 and PRRT2 interact with SNARE proteins to put the brakes on membrane fusion.
Key negative regulators include RUNDC1, which restrains autophagosome-lysosome fusion by limiting SNARE complex assembly. PRRT2 regulates synaptic fusion by directly modulating SNARE complex assembly, and its dysfunction leads to neurological disorders. Other proteins such as CAPS-1 and Munc13-1 influence exocytosis through intramolecular regulation and membrane anchoring, indirectly affecting SNARE assembly. The lactate sensor NDRG3 interacts with syntaxin-5 to decelerate ER-to-Golgi transport, demonstrating metabolic control of SNARE assembly.
Regulation of Autophagosome-Lysosome Fusion
In simple terms: During autophagy, negative regulators ensure that autophagosomes fuse with lysosomes at the right time and place.
Autophagosome-lysosome fusion requires SNARE complex assembly, and negative regulators like RUNDC1 modulate this process. ATG2A acts as a tether to regulate autophagosome-lysosome fusion in neural cells, and its function is linked to SNARE assembly. The STX17-containing SNARE complex is evolutionarily conserved and essential for autophagosome fusion with endosomes and lysosomes. Negative regulation prevents premature fusion and ensures efficient cargo degradation.
Synaptic Vesicle Release and Neurotransmission
In simple terms: In neurons, negative regulators control the release of neurotransmitters by modulating SNARE assembly.
APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly, leading to synaptic dysfunction. PRRT2 regulates synaptic fusion by directly modulating SNARE complex assembly, and mutations in PRRT2 are associated with paroxysmal kinesigenic dyskinesia. CAPS-1 and Munc13-1 are critical for vesicle exocytosis, with their regulatory domains influencing SNARE assembly. Negative regulation ensures precise control of neurotransmitter release.
Metabolic and Transport Regulation
In simple terms: Metabolic signals can also put the brakes on SNARE assembly to adjust intracellular transport.
NDRG3, a lactate sensor, decelerates ER-to-Golgi transport through interaction with the long isoform of syntaxin-5, thereby negatively regulating SNARE complex assembly. This highlights how metabolic cues can modulate membrane trafficking. Such regulation is important for adapting secretion and transport to cellular metabolic states.
Key Genes Involved in GO:0035544 negative regulation of SNARE complex assembly
The following genes and proteins are key players in the negative regulation of SNARE complex assembly, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RUNDC1 | Negatively mediates autophagosome-lysosome fusion by regulating SNARE complex assembly | Autophagy regulation, potential target for autophagy-related diseases |
| PRRT2 | Directly modulates SNARE complex assembly, regulating synaptic fusion | Neurological disorders, synaptic transmission research |
| APOE4 | Disrupts SNARE complex assembly, leading to dysregulated synaptic vesicle release | Alzheimer's disease risk factor, neurodegeneration |
| NDRG3 | Lactate sensor that decelerates ER-to-Golgi transport via syntaxin-5 interaction | Metabolic regulation of membrane trafficking |
| CAPS-1 | Anchors plasma membrane to promote vesicle exocytosis, influencing SNARE assembly | Exocytosis, synaptic vesicle release |
| Munc13-1 | Intramolecular regulation via negatively charged sequence modulates synaptic exocytosis | Synaptic transmission, exocytosis machinery |
| ATG2A | Acts as a tether to regulate autophagosome-lysosome fusion | Autophagy, neural cell biology |
| STX17 | Forms SNARE complex with SNAP29 and VAMP8 for autophagosome fusion | Autophagy, evolutionarily conserved fusion |
| SNAP29 | Q-SNARE involved in autophagosome-lysosome fusion | SNARE complex assembly, autophagy |
| VAMP8 | R-SNARE involved in autophagosome-lysosome fusion | SNARE complex assembly, autophagy |
| Syntaxin-5 | Target SNARE involved in ER-to-Golgi transport, regulated by NDRG3 | ER-Golgi trafficking, metabolic regulation |
| SNAP-25 | Q-SNARE in synaptic vesicle fusion, target of PRRT2 modulation | Neurotransmission, synaptic fusion |
| Syntaxin-1 | Q-SNARE in synaptic vesicle fusion, interacts with PRRT2 | Synaptic exocytosis |
| VAMP2 | R-SNARE in synaptic vesicle fusion, modulated by PRRT2 | Synaptic vesicle release |
| Complexin | Regulates SNARE complex assembly, though not directly cited in provided list | Synaptic transmission (general knowledge, not cited) |
| Tomosyn | Negative regulator of SNARE assembly, not directly cited in provided list | Synaptic transmission (general knowledge, not cited) |
How Is negative regulation of SNARE complex assembly Regulated?
The negative regulation of SNARE complex assembly is itself subject to regulation by various cellular signals. For example, the lactate sensor NDRG3 decelerates ER-to-Golgi transport through interaction with syntaxin-5, linking metabolic status to SNARE assembly. Intramolecular regulation of Munc13-1 by a negatively charged sequence modulates synaptic exocytosis, providing a mechanism for autoinhibition. Additionally, the DID of CAPS-1 anchors the plasma membrane to promote vesicle exocytosis, indirectly influencing SNARE assembly. These examples illustrate that negative regulation can be controlled by metabolic cues, intramolecular interactions, and protein-protein interactions.
negative regulation of SNARE complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOE4 | Alzheimer's disease, synaptic dysfunction | Knock-in mice or human iPSC-derived neurons with APOE4 |
| PRRT2 | Paroxysmal kinesigenic dyskinesia, synaptic disorders | PRRT2 knockout or point-mutation cell models |
| RUNDC1 | Autophagy-related diseases, cancer | RUNDC1 knockout cell lines, autophagy flux assays |
| NDRG3 | Metabolic regulation, ER-Golgi transport defects | NDRG3 knockout or overexpression cell models |
| ATG2A | Neurodegeneration, autophagy defects | ATG2A knockout neural cells |
Neurodegeneration and Alzheimer's Disease
APOE4, the strongest genetic risk factor for Alzheimer's disease, triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly. This disruption contributes to synaptic dysfunction and neurodegeneration. Understanding how APOE4 negatively regulates SNARE assembly may reveal therapeutic targets for Alzheimer's disease.
Neurological Disorders Linked to PRRT2
PRRT2 regulates synaptic fusion by directly modulating SNARE complex assembly, and mutations in PRRT2 are associated with paroxysmal kinesigenic dyskinesia and other neurological disorders. The negative regulatory role of PRRT2 in SNARE assembly is critical for proper synaptic transmission, and its dysfunction leads to disease.
Autophagy-Related Diseases
RUNDC1 negatively mediates the fusion of autophagosomes with lysosomes by regulating SNARE complex assembly. Dysregulation of this process can lead to impaired autophagy, which is implicated in neurodegenerative diseases, cancer, and metabolic disorders. ATG2A also regulates autophagosome-lysosome fusion, and its dysfunction may contribute to similar pathologies.
From negative regulation of SNARE complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RUNDC1 negatively regulate SNARE assembly in autophagy? | RUNDC1 knockout HeLa or HEK293 cells with autophagy flux assays |
| How does PRRT2 modulate SNARE complex assembly? | PRRT2 knockout or point-mutation neuronal cell lines |
| What is the effect of APOE4 on SNARE assembly? | APOE4 knock-in iPSC-derived neurons |
| How does NDRG3 regulate ER-to-Golgi transport? | NDRG3 overexpression or knockout cell models |
| What is the role of CAPS-1 in vesicle exocytosis? | CAPS-1 knockout or tagged knock-in cell lines |
| How does Munc13-1 intramolecular regulation affect exocytosis? | Munc13-1 point-mutation knock-in models |
How to Study the negative regulation of SNARE complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interactions | Detect binding between SNARE proteins and regulators |
| FRET | SNARE complex assembly in live cells | Monitor real-time assembly dynamics |
| CRISPR knockout screening | Identification of negative regulators | Genome-wide screens for SNARE assembly modulators |
| Autophagy flux assay | Autophagosome-lysosome fusion | Assess RUNDC1 or ATG2A function |
| Synaptic vesicle release assay | Neurotransmitter release | Study APOE4 or PRRT2 effects |
| Proteomics | Protein interactions and modifications | Identify SNARE complex components |
| Live-cell imaging | Localization and dynamics | Visualize SNARE assembly at membranes |
Co-Immunoprecipitation and Pull-Down Assays
Co-immunoprecipitation (co-IP) is used to detect interactions between SNARE proteins and negative regulators such as RUNDC1 or PRRT2. For example, co-IP can assess whether RUNDC1 binds to STX17 or other SNARE components to inhibit assembly. Pull-down assays with GST-tagged SNARE domains can identify direct binding partners.
FRET and Fluorescence Microscopy
FRET-based sensors can monitor SNARE complex assembly in live cells. This approach has been used to study PRRT2 modulation of SNARE assembly. Fluorescence microscopy can visualize co-localization of SNARE proteins and regulators at specific membrane compartments.
CRISPR Screening and Functional Genomics
CRISPR knockout library screening can identify novel negative regulators of SNARE complex assembly. For instance, a genome-wide screen could reveal genes whose loss increases SNARE assembly, as measured by reporter assays. This unbiased approach complements candidate-based studies.
Autophagy Flux and Synaptic Vesicle Release Assays
Autophagy flux assays, such as LC3-II turnover, measure the impact of negative regulators on autophagosome-lysosome fusion. Synaptic vesicle release can be quantified using pHluorin-based imaging or electrophysiology in neurons with manipulated SNARE regulators.
How CRISPR Can Be Used to Study GO:0035544 negative regulation of SNARE complex assembly
Knockout
CRISPR knockout of negative regulators such as RUNDC1 or PRRT2 can be used to assess their role in SNARE complex assembly. For example, RUNDC1 knockout cells may show increased autophagosome-lysosome fusion due to loss of negative regulation. PRRT2 knockout neurons can be used to study synaptic fusion defects.
Point Mutation
Point mutations can be introduced into genes encoding SNARE proteins or their regulators to mimic disease-associated variants. For instance, PRRT2 point mutations found in patients can be knocked into cell lines to study their impact on SNARE assembly. Similarly, mutations in Munc13-1 can be modeled to understand intramolecular regulation.
Knock-in
Knock-in of tagged versions of SNARE proteins or regulators (e.g., GFP-STX17) allows for live-cell imaging and co-IP studies. This approach can reveal dynamic assembly and localization. Knock-in of disease variants, such as APOE4, in iPSCs provides a model for neurodegeneration research.
Overexpression
Overexpression of negative regulators like RUNDC1 or PRRT2 can suppress SNARE complex assembly, leading to reduced membrane fusion. This is useful to confirm their inhibitory function. Overexpression of NDRG3 can decelerate ER-to-Golgi transport, demonstrating its regulatory role.
How EDITGENE Supports negative regulation of SNARE complex assembly Research
Researchers studying negative regulation of SNARE complex assembly-related genes often need to determine whether a candidate gene is causally involved in modulating SNARE assembly and downstream membrane fusion. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of SNARE complex assembly research.
Frequently Asked Questions About negative regulation of SNARE complex assembly
What is negative regulation of SNARE complex assembly?
It is a biological process (GO:0035544) that decreases the frequency, rate or extent of SNARE complex assembly, thereby modulating membrane fusion.
What genes are involved in negative regulation of SNARE complex assembly?
Key genes include RUNDC1, PRRT2, APOE4, NDRG3, CAPS-1, Munc13-1, and ATG2A, among others.
How does RUNDC1 regulate SNARE complex assembly?
RUNDC1 negatively mediates the fusion of autophagosomes with lysosomes by regulating SNARE complex assembly, likely by inhibiting STX17-SNAP29-VAMP8 complex formation.
What is the role of PRRT2 in SNARE complex assembly?
PRRT2 directly modulates SNARE complex assembly to regulate synaptic fusion, and its mutations are linked to neurological disorders.
How is SNARE complex assembly regulated in autophagy?
Negative regulators like RUNDC1 and ATG2A control autophagosome-lysosome fusion by modulating SNARE complex assembly.
What diseases are associated with dysregulated SNARE complex assembly?
Alzheimer's disease, paroxysmal kinesigenic dyskinesia, and autophagy-related disorders are linked to dysregulated SNARE assembly.
What methods are used to study negative regulation of SNARE complex assembly?
Common methods include co-immunoprecipitation, FRET, CRISPR screening, autophagy flux assays, and synaptic vesicle release assays.
How does APOE4 affect SNARE complex assembly?
APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly, contributing to Alzheimer's disease pathogenesis.
What is the role of NDRG3 in SNARE assembly?
NDRG3, a lactate sensor, decelerates ER-to-Golgi transport through interaction with syntaxin-5, negatively regulating SNARE complex assembly.
Can CRISPR be used to study negative regulation of SNARE complex assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the roles of specific genes in SNARE assembly.
Conclusion
Negative regulation of SNARE complex assembly (GO:0035544) is a critical biological process that ensures precise control of membrane fusion events. Key regulators such as RUNDC1, PRRT2, and APOE4 modulate SNARE assembly to influence autophagy, synaptic transmission, and intracellular transport. Dysregulation of this process is implicated in neurodegenerative diseases and autophagy-related pathologies, making it a compelling area for therapeutic intervention. Continued research using advanced CRISPR models and functional assays will further elucidate the molecular mechanisms and disease relevance of this regulatory pathway.
References
- 1. Chen F et al.. 2025. APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly.. Cell Mol Life Sci 82(1):248 PMID: 40549157
- 2. Zheng Z et al.. 2025. ATG2A acts as a tether to regulate autophagosome-lysosome fusion in neural cells.. Autophagy 21(8):1767-1778 PMID: 40083067
- 3. Zhang R et al.. 2024. RUNDC1 negatively mediates the fusion of autophagosomes with lysosomes via regulating SNARE complex assembly.. Autophagy 20(2):454-456 PMID: 37876308
- 4. Coleman J et al.. 2018. PRRT2 Regulates Synaptic Fusion by Directly Modulating SNARE Complex Assembly.. Cell Rep 22(3):820-831 PMID: 29346777
- 5. Zhang L et al.. 2025. The DID of CAPS-1 anchors plasma membrane to promote vesicle exocytosis.. J Biol Chem 301(12):110902 PMID: 41197722
- 6. Ferle PE et al.. 2025. The lactate sensor NDRG3 decelerates ER-to-Golgi transport through interaction with the long isoform of syntaxin-5.. Proc Natl Acad Sci U S A 122(47):e2511307122 PMID: 41252154
- 7. Hegedűs K et al.. 2013. Evolutionarily conserved role and physiological relevance of a STX17/Syx17 (syntaxin 17)-containing SNARE complex in autophagosome fusion with endosomes and lysosomes.. Autophagy 9(10):1642-6 PMID: 24113031
- 8. Zhao K et al.. 2025. A specific negatively charged sequence confers intramolecular regulation on Munc13-1 function in synaptic exocytosis.. Proc Natl Acad Sci U S A 122(24):e2508915122 PMID: 40489622
